☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
T3D Therapeutics
T3D Therapeutics Reports Positive Results from the P-II (PIONEER) Study of T3D-959 for Alzheimer’s Disease
November 3, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.